Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells

BJU International

Volumn 100, Issue 1, 2007, Pages 199-203

  Thelen, Paul ^a   Peter, Thomas ^a   Hünermund, Anika ^a   Kaulfuß, Silke ^a   Seidlová Wuttke, Dana ^a   Wuttke, Wolfgang ^a   Ringert, Rolf Hermann ^a   Seseke, Florian ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Androgen receptor; LNCaP; Oestrogen; Phytoestrogens; Proliferation; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; BELAMCANDA CHINENSIS EXTRACT; ESTROGEN RECEPTOR BETA; MESSENGER RNA; PHYTOESTROGEN; PLANT EXTRACT; PORPHOBILINOGEN DEAMINASE; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR NKX 3.1; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BELAMCANDA CHINENSIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN LNCAP; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DOWN REGULATION; HORMONAL REGULATION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MALE; MEDICINAL PLANT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY EFFECT; TREATMENT OUTCOME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; IRIDACEAE; MALE; MICE; MICE, NUDE; PHYTOESTROGENS; PLANT EXTRACTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 34249940757     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06924.x     Document Type: Article

References (21)

1. Nelson PS, Montgomery B. Unconventional therapy for prostate cancer: good, bad, or questionable? Nat Rev Cancer 2003 3 : 845 58
2. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med 1997 29 : 95 120
3. Denis L, Morton MS, Griffiths K. Diet and its preventive role in prostatic disease. Eur Urol 1999 35 : 377 87
4. Cos P, De Bruyne T, Apers S, Van den Berghe D, Pieters L, Vlietinck AJ. Phytooestrogens: recent developments. Planta Med 2003 69 : 589 99
5. Steiner MS, Raghow S. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World J Urol 2003 21 : 31 6
6. Chen CD, Welsbie DS, Tran C et al. Molecular deteminants of resistance to antiandrogen therapy. Nat Med 2004 10 : 33 9
7. Schellhammer PF, Venner P, Haas GP et al. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade. J Urol 1997 157 : 1731 5
8. Ghadersohi A, Odunsi K, Lele S et al. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules. Oncol Rep 2004 11 : 453 8
9. Chen H, Nandi AK, Li X, Bieberich CJ. NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res 2002 62 : 338 40
10. Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes Dev 2000 14 : 2410 34
11. Jung SH, Lee YS, Lee S et al. Anti-angiogenic and anti-tumor activities of isoflavonoids from the rhizomes of Belamcanda chinensis. Planta Med 2003 69 : 617 22
12. Morrissey C, Bektic J, Spengler B et al. Phytooestrogens derived from Belamcanda chinensis have an antiproliferative effect on prostate cancer cells in vitro. J Urol 2004 172 : 2426 33
13. Thelen P, Scharf JG, Burfeind P et al. Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer. Carcinogenesis 2005 36 : 1360 7
14. Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001 1 : 34 45
15. Korkmaz KS, Korkmaz CG, Ragnhildstveit E, Kizildag S, Pretlow TG, Saatcioglu F. Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens. Gene 2000 260 : 25 36
16. Xing N, Chen Y, Mitchell SH, Young CY. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 2001 22 : 409 14
17. Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C. Loss-of-function of NKX3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 2005 65 : 6773 9
18. Kuiper GG, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998 139 : 4252 63
19. Cheng J, Lee EJ, Madison LD, Lazennec G. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Lett 2004 566 : 169 72
20. Krege JH, Hodgin JB, Couse JF et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998 95 : 15677 82
21. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H. Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol 2004 45 : 245 51